» Articles » PMID: 8995670

Mutations in the Matrix Protein of Human Immunodeficiency Virus Type 1 Inhibit Surface Expression and Virion Incorporation of Viral Envelope Glycoproteins in CD4+ T Lymphocytes

Overview
Journal J Virol
Date 1997 Feb 1
PMID 8995670
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Highly conserved amino acids in the second helix structure of the human immunodeficiency virus type 1 (HIV-1) MA protein were identified to be critical for the incorporation of viral Env proteins into HIV-1 virions from transfected COS-7 cells. The effects of these MA mutations on viral replication in the HIV-1 natural target cells, CD4+ T lymphocytes, were evaluated by using a newly developed system. In CD4+ T lymphocytes, mutations in the MA domain of HIV-1 Gag also inhibited the incorporation of viral Env proteins into mature HIV-1 virions. Furthermore, mutations in the MA domain of HIV-1 Gag reduced surface expression of viral Env proteins in CD4+ T lymphocytes. The synthesis of gp160 and cleavage of gp160 to gp120 were not significantly affected by MA mutations. On the other hand, the stability of gp120 in MA mutant-infected cells was significantly reduced compared to that in the parental wild-type virus-infected cells. These results suggest that functional interaction between HIV-1 Gag and Env proteins is not only critical for efficient incorporation of Env proteins into mature virions but also important for proper intracellular transport and stable surface expression of viral Env proteins in infected CD4+ T lymphocytes. A single amino acid substitution in MA abolished virus infectivity in dividing CD4+ T lymphocytes without significantly affecting virus assembly, virus release, or incorporation of Gag-Pol and Env proteins, suggesting that in addition to its functional role in virus assembly, the MA protein of HIV-1 also plays an important role in other steps of virus replication.

Citing Articles

The host restriction factor SERINC5 inhibits HIV-1 transcription by negatively regulating NF-κB signaling.

Li W, Qu M, Zhang T, Li G, Wang R, Tian Y J Biol Chem. 2024; 301(1):108058.

PMID: 39653243 PMC: 11750542. DOI: 10.1016/j.jbc.2024.108058.


Design of Vif-Derived Peptide Inhibitors with Anti-HIV-1 Activity by Interrupting Vif-CBFβ Interaction.

Gai Y, Duan S, Wang S, Liu K, Yu X, Yang C Viruses. 2024; 16(4).

PMID: 38675833 PMC: 11053914. DOI: 10.3390/v16040490.


Dominant Negative Mutants of Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) Disrupt Core-Binding Factor Beta-Vif Interaction.

Duan S, Yu X, Wang C, Meng L, Gai Y, Zhou Y J Virol. 2022; 96(17):e0055522.

PMID: 35950859 PMC: 9472641. DOI: 10.1128/jvi.00555-22.


Advances in HIV-1 Assembly.

Lerner G, Weaver N, Anokhin B, Spearman P Viruses. 2022; 14(3).

PMID: 35336885 PMC: 8952333. DOI: 10.3390/v14030478.


Elucidating the Basis for Permissivity of the MT-4 T-Cell Line to Replication of an HIV-1 Mutant Lacking the gp41 Cytoplasmic Tail.

Fernandez M, Hoffman H, Pezeshkian N, Tedbury P, van Engelenburg S, Freed E J Virol. 2020; 94(23).

PMID: 32938764 PMC: 7654282. DOI: 10.1128/JVI.01334-20.


References
1.
Owens R, Dubay J, Hunter E, Compans R . Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc Natl Acad Sci U S A. 1991; 88(9):3987-91. PMC: 51578. DOI: 10.1073/pnas.88.9.3987. View

2.
Vzorov A, Compans R . Assembly and release of SIV env proteins with full-length or truncated cytoplasmic domains. Virology. 1996; 221(1):22-33. DOI: 10.1006/viro.1996.0349. View

3.
Gabuzda D, Lever A, Terwilliger E, Sodroski J . Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J Virol. 1992; 66(6):3306-15. PMC: 241108. DOI: 10.1128/JVI.66.6.3306-3315.1992. View

4.
Wilk T, Pfeiffer T, Bosch V . Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology. 1992; 189(1):167-77. DOI: 10.1016/0042-6822(92)90692-i. View

5.
Yu X, Yuan X, Matsuda Z, Lee T, Essex M . The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J Virol. 1992; 66(8):4966-71. PMC: 241345. DOI: 10.1128/JVI.66.8.4966-4971.1992. View